Incidental vs symptomatic renal tumours

Survival outcomes

Mohammed S. Al-Marhoon, Ahmed Mosbah Osman, Mohammed M. Kamal, Ahmed A. Shokeir

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Purpose: Currently there is an increase in the incidental diagnosis of renal cell carcinoma (RCC). Our aim was to assess the survival of patients with incidental and symptomatic renal tumours who had undergone nephrectomy. Patients and methods: We retrospectively assessed 604 patients who underwent renal surgery for RCC between 1983 and 2005. Patients were divided in two groups; group 1 had incidental and group 2 had symptomatic tumours. The median follow-up was 4 and 3.3 years for groups 1 and 2, respectively. All patients had surgery in the form of radical or partial nephrectomy. Sex, age, tumour size, type of surgery, pathological characteristics and patient survival in both groups were evaluated. The statistical analysis included the log-rank, Kaplan-Meier and Cox regression tests. Results: There were 85 patients (14%) in group 1 (mean age 49.6 years) and 519 (86%) in group 2 (mean age 50 years). The mean (SEM, range) tumour size was 7.4 (0.4, 1.5-20) cm in group 1 and 9.7 (0.2, 2-38) cm in group 2 (P < 0.001). The most common stage was T1 (52%) and T2 (44%) in groups 1 and 2, respectively, with a predominance of G2 grade and the conventional type histology in both the groups. There was a significant difference in cancer-specific survival (CSS) between the groups (log-rank, P = 0.017). The 5- and 10-year CSS was 94% and 94% for group 1, and 82.5% and 79.5% for group 2. Cox regression analysis showed that in group 1, only the tumour mid-zonal location (P = 0.093), tumour stage pT (P < 0.001), grade 1 (P = 0.03), grade 2 (P = 0.01), grade 4 (P = 0.01) and the papillary histological type (P = 0.019) had significant effects on CSS. In group 2, only tumour size (P = 0.022) and stage pN (P = 0.003) had significant effects on CSS. The tumour recurrence rate was 18% and 29% for groups 1 and 2, respectively. Conclusions: This large study supports the findings of other smaller studies published previously, confirming that at presentation incidental renal tumours are smaller and their diagnosis provides a better prognosis and longer CSS.

Original languageEnglish
Pages (from-to)17-21
Number of pages5
JournalArab Journal of Urology
Volume9
Issue number1
DOIs
Publication statusPublished - Mar 2011

Fingerprint

Kidney
Survival
Neoplasms
Nephrectomy
Renal Cell Carcinoma
Histology
Regression Analysis
Recurrence

Keywords

  • Incidental
  • Renal cell carcinoma
  • Survival

ASJC Scopus subject areas

  • Urology

Cite this

Incidental vs symptomatic renal tumours : Survival outcomes. / Al-Marhoon, Mohammed S.; Osman, Ahmed Mosbah; Kamal, Mohammed M.; Shokeir, Ahmed A.

In: Arab Journal of Urology, Vol. 9, No. 1, 03.2011, p. 17-21.

Research output: Contribution to journalArticle

Al-Marhoon, Mohammed S. ; Osman, Ahmed Mosbah ; Kamal, Mohammed M. ; Shokeir, Ahmed A. / Incidental vs symptomatic renal tumours : Survival outcomes. In: Arab Journal of Urology. 2011 ; Vol. 9, No. 1. pp. 17-21.
@article{cb6c704bd82c4faa909d3ce92650357c,
title = "Incidental vs symptomatic renal tumours: Survival outcomes",
abstract = "Purpose: Currently there is an increase in the incidental diagnosis of renal cell carcinoma (RCC). Our aim was to assess the survival of patients with incidental and symptomatic renal tumours who had undergone nephrectomy. Patients and methods: We retrospectively assessed 604 patients who underwent renal surgery for RCC between 1983 and 2005. Patients were divided in two groups; group 1 had incidental and group 2 had symptomatic tumours. The median follow-up was 4 and 3.3 years for groups 1 and 2, respectively. All patients had surgery in the form of radical or partial nephrectomy. Sex, age, tumour size, type of surgery, pathological characteristics and patient survival in both groups were evaluated. The statistical analysis included the log-rank, Kaplan-Meier and Cox regression tests. Results: There were 85 patients (14{\%}) in group 1 (mean age 49.6 years) and 519 (86{\%}) in group 2 (mean age 50 years). The mean (SEM, range) tumour size was 7.4 (0.4, 1.5-20) cm in group 1 and 9.7 (0.2, 2-38) cm in group 2 (P < 0.001). The most common stage was T1 (52{\%}) and T2 (44{\%}) in groups 1 and 2, respectively, with a predominance of G2 grade and the conventional type histology in both the groups. There was a significant difference in cancer-specific survival (CSS) between the groups (log-rank, P = 0.017). The 5- and 10-year CSS was 94{\%} and 94{\%} for group 1, and 82.5{\%} and 79.5{\%} for group 2. Cox regression analysis showed that in group 1, only the tumour mid-zonal location (P = 0.093), tumour stage pT (P < 0.001), grade 1 (P = 0.03), grade 2 (P = 0.01), grade 4 (P = 0.01) and the papillary histological type (P = 0.019) had significant effects on CSS. In group 2, only tumour size (P = 0.022) and stage pN (P = 0.003) had significant effects on CSS. The tumour recurrence rate was 18{\%} and 29{\%} for groups 1 and 2, respectively. Conclusions: This large study supports the findings of other smaller studies published previously, confirming that at presentation incidental renal tumours are smaller and their diagnosis provides a better prognosis and longer CSS.",
keywords = "Incidental, Renal cell carcinoma, Survival",
author = "Al-Marhoon, {Mohammed S.} and Osman, {Ahmed Mosbah} and Kamal, {Mohammed M.} and Shokeir, {Ahmed A.}",
year = "2011",
month = "3",
doi = "10.1016/j.aju.2011.03.006",
language = "English",
volume = "9",
pages = "17--21",
journal = "Arab Journal of Urology",
issn = "2090-598X",
publisher = "Elsevier BV",
number = "1",

}

TY - JOUR

T1 - Incidental vs symptomatic renal tumours

T2 - Survival outcomes

AU - Al-Marhoon, Mohammed S.

AU - Osman, Ahmed Mosbah

AU - Kamal, Mohammed M.

AU - Shokeir, Ahmed A.

PY - 2011/3

Y1 - 2011/3

N2 - Purpose: Currently there is an increase in the incidental diagnosis of renal cell carcinoma (RCC). Our aim was to assess the survival of patients with incidental and symptomatic renal tumours who had undergone nephrectomy. Patients and methods: We retrospectively assessed 604 patients who underwent renal surgery for RCC between 1983 and 2005. Patients were divided in two groups; group 1 had incidental and group 2 had symptomatic tumours. The median follow-up was 4 and 3.3 years for groups 1 and 2, respectively. All patients had surgery in the form of radical or partial nephrectomy. Sex, age, tumour size, type of surgery, pathological characteristics and patient survival in both groups were evaluated. The statistical analysis included the log-rank, Kaplan-Meier and Cox regression tests. Results: There were 85 patients (14%) in group 1 (mean age 49.6 years) and 519 (86%) in group 2 (mean age 50 years). The mean (SEM, range) tumour size was 7.4 (0.4, 1.5-20) cm in group 1 and 9.7 (0.2, 2-38) cm in group 2 (P < 0.001). The most common stage was T1 (52%) and T2 (44%) in groups 1 and 2, respectively, with a predominance of G2 grade and the conventional type histology in both the groups. There was a significant difference in cancer-specific survival (CSS) between the groups (log-rank, P = 0.017). The 5- and 10-year CSS was 94% and 94% for group 1, and 82.5% and 79.5% for group 2. Cox regression analysis showed that in group 1, only the tumour mid-zonal location (P = 0.093), tumour stage pT (P < 0.001), grade 1 (P = 0.03), grade 2 (P = 0.01), grade 4 (P = 0.01) and the papillary histological type (P = 0.019) had significant effects on CSS. In group 2, only tumour size (P = 0.022) and stage pN (P = 0.003) had significant effects on CSS. The tumour recurrence rate was 18% and 29% for groups 1 and 2, respectively. Conclusions: This large study supports the findings of other smaller studies published previously, confirming that at presentation incidental renal tumours are smaller and their diagnosis provides a better prognosis and longer CSS.

AB - Purpose: Currently there is an increase in the incidental diagnosis of renal cell carcinoma (RCC). Our aim was to assess the survival of patients with incidental and symptomatic renal tumours who had undergone nephrectomy. Patients and methods: We retrospectively assessed 604 patients who underwent renal surgery for RCC between 1983 and 2005. Patients were divided in two groups; group 1 had incidental and group 2 had symptomatic tumours. The median follow-up was 4 and 3.3 years for groups 1 and 2, respectively. All patients had surgery in the form of radical or partial nephrectomy. Sex, age, tumour size, type of surgery, pathological characteristics and patient survival in both groups were evaluated. The statistical analysis included the log-rank, Kaplan-Meier and Cox regression tests. Results: There were 85 patients (14%) in group 1 (mean age 49.6 years) and 519 (86%) in group 2 (mean age 50 years). The mean (SEM, range) tumour size was 7.4 (0.4, 1.5-20) cm in group 1 and 9.7 (0.2, 2-38) cm in group 2 (P < 0.001). The most common stage was T1 (52%) and T2 (44%) in groups 1 and 2, respectively, with a predominance of G2 grade and the conventional type histology in both the groups. There was a significant difference in cancer-specific survival (CSS) between the groups (log-rank, P = 0.017). The 5- and 10-year CSS was 94% and 94% for group 1, and 82.5% and 79.5% for group 2. Cox regression analysis showed that in group 1, only the tumour mid-zonal location (P = 0.093), tumour stage pT (P < 0.001), grade 1 (P = 0.03), grade 2 (P = 0.01), grade 4 (P = 0.01) and the papillary histological type (P = 0.019) had significant effects on CSS. In group 2, only tumour size (P = 0.022) and stage pN (P = 0.003) had significant effects on CSS. The tumour recurrence rate was 18% and 29% for groups 1 and 2, respectively. Conclusions: This large study supports the findings of other smaller studies published previously, confirming that at presentation incidental renal tumours are smaller and their diagnosis provides a better prognosis and longer CSS.

KW - Incidental

KW - Renal cell carcinoma

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=84865193668&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865193668&partnerID=8YFLogxK

U2 - 10.1016/j.aju.2011.03.006

DO - 10.1016/j.aju.2011.03.006

M3 - Article

VL - 9

SP - 17

EP - 21

JO - Arab Journal of Urology

JF - Arab Journal of Urology

SN - 2090-598X

IS - 1

ER -